Description
Composition- Sitagliptin 100 mg
Mode of Action- DPP-4 inhibitor that increases incretin activity, improving glucose-dependent insulin secretion and reducing glucagon release in type 2 diabetes.
USPs- Effective oral antidiabetic support; low hypoglycemia risk; suitable for type 2 diabetes management.
Prescribing Specialties- Diabetologist, General Physician, Internal Medicine
